Acetylcholine Receptor Binding Antibody Blood Test

What this test measures

Myasthenia gravis is an autoimmune condition in which the immune system produces antibodies against proteins at the neuromuscular junction. The most common target is the acetylcholine receptor, a structure on the muscle side of the junction that receives nerve signals. Detecting these antibodies gives clinicians an objective clue when someone reports fluctuating weakness, drooping eyelids, or difficulty with speech and swallowing.

The binding antibody assay is the standard first step and is positive in a large share of people with generalized myasthenia gravis. When binding antibodies are not detected but the clinical picture still suggests the condition, laboratories may add blocking or modulating antibody tests, or related markers such as muscle-specific kinase antibodies. The test requires only a blood sample.

Results do not stand alone. Some people with the condition test negative on available antibody assays, and antibodies can occasionally appear in other settings. Clinicians combine the laboratory result with symptoms, examination findings, and sometimes electrical or imaging studies before reaching a conclusion.

• Acetylcholine receptor (AChR) binding antibodies
• AChR blocking antibodies
• AChR modulating antibodies
• Muscle-specific kinase (MuSK) antibodies
• LRP4 antibodies
• Titin antibodies
• Striated muscle antibodies
• AChR antibody titer level

Why people order this test

• Evaluate unexplained muscle weakness that worsens with activity
• Support the diagnostic workup of suspected myasthenia gravis
• Monitor antibody levels during ongoing care
• Distinguish myasthenia gravis from other neuromuscular conditions
• Investigate drooping eyelids or double vision with a fluctuating pattern
• Follow up when an initial antibody result needs confirmation

How to prepare

No fasting is required. A blood sample is drawn from a vein, usually at the arm. Certain treatments can affect antibody levels over time, so sharing a current medication list with the ordering provider supports accurate interpretation.

Understanding your results

Results are typically available within one to three business days. A positive binding antibody result supports the evaluation of myasthenia gravis, while a negative result does not rule it out. A qualified healthcare provider interprets the findings alongside symptoms and other testing.